v3.25.2
Condensed Consolidated Statements of Income and Comprehensive (Loss) Income - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Revenues    
Total revenues $ 14,260 $ 18,096
Cost of revenues (7,665) (7,131)
Gross profit 6,595 10,965
Operating expenses:    
Selling and marketing (5,910) (3,783)
General and administrative (5,932) (5,480)
Total operating expenses (11,842) (9,263)
(Loss) Income from operations (5,247) 1,702
Other income (expense)    
Other (expense) income, net (3,858) 46
Interest income 11 19
(Loss) Income before income taxes (9,094) 1,767
Income tax expenses (88) (1,000)
Net (loss) income (9,182) 767
Less: Net income attributable to non-controlling interests 174 0
Net (loss) income attributable to Lichen International Limited (9,356) 767
Comprehensive (loss) income:    
Net (loss) income (9,182) 767
Foreign currency translation adjustments 154 (681)
Comprehensive (loss) income $ (9,028) $ 86
Weighted average number of ordinary shares outstanding – diluted (in Shares) [1] 282,846 169,988
Weighted average number of ordinary shares outstanding – basic (in Shares) [1] 282,846 169,988
(Loss) Earnings per ordinary share – diluted (in Dollars per share) [1] $ (32.46) $ 4.51
(Loss) Earnings per ordinary share – basic (in Dollars per share) [1] $ (32.46) $ 4.51
Financial and taxation solution services    
Revenues    
Total revenues $ 11,579 $ 14,395
Education support services    
Revenues    
Total revenues 760 1,609
Software and maintenance services    
Revenues    
Total revenues 1,330 2,092
Pre-IPO advisory services    
Revenues    
Total revenues $ 591 $ 0
[1] On March 3, 2025, the Company consolidated (each a “Share”) its common shares on the basis of 200 pre-consolidation Shares for one (1) post-consolidation share, which was approved by the Board on February 10, 2025. Share amounts have been retrospectively restated to reflect the post-consolidation number of shares.